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Abstract
Alterations of the gutmicrobiome have been associatedwith obesity andmetabolic disorders. The gutmicrobiota can be influenced by the intake
of dietary fibres with prebiotic properties, such as inulin-type fructans. The present study tested the hypothesis that obese individuals subjected
for 12 weeks to an inulin-enriched v. inulin-poor diet have differential faecal fermentation patterns. The fermentation of cellulose and inulin
hydrolysates of six different inulin-rich and inulin-poor vegetables of both groups was analysed in vitro on faecal inocula. The results showed
that the microbiota from obese patients who received a fructan-rich diet for 3 weeks produces more gas and total SCFA compared with the
microbiota taken from the same individuals before the treatment. Obese individuals fed with a low-fructan diet produce less gas and less
SCFA compared with the treated group. The present study highlighted profound changes in microbiota fermentation capacity obtained by pre-
biotic intervention in obese individuals, which favours the production of specific bioactive metabolites.
Key words: In vitro fermentation: Obese adults: Fibre residues: Inulin
The large intestine of humans hosts an important microbial
population that can reach 1010–1011 bacteria cells/g of intestinal
content, with nearly 400–1000 species(1–3). This gut microbiota
plays a key role in homeostasis and health status by interfering
with digestion processes, preventing colonisation by pathogens
and modulating the development of the immune system(4). It
also regulates a set of metabolic pathways of the host(5,6).
Many metabolic diseases, such as obesity, the metabolic syn-
drome, diabetes and gastrointestinal diseases such as cancer
and inflammatory bowel disease, are related to alterations of
gut microbiota composition and function, called dysbiosis(7,8).
The gut microbiota is highly influenced by the diet. In particu-
lar, the undigested carbohydrates and proteins that reach the
large intestine are subjected to fermentation. Hence, intestinal
microbes produce gases, such as H2, carbon dioxide, methane,
ammonia and hydrogen sulphide (H2S)(9), as well as various
metabolites, such as SCFA and branched-chain fatty acids
(BCFA), phenolic and indole compounds, biogenic amines
and sulphur metabolites(10).
All these compounds influence the physiological and meta-
bolic functions in humans(11,12). SCFA are linear carboxylic acids,
including acetate, propionate and butyrate, and are produced
from fermentation of carbohydrates and fibres. The main
BCFA are iso-valerate, iso-butyrate and valerate(13). BCFA origi-
nate from the fermentation of protein and the degradation of
their constitutive amino acids(14).
Several studies have demonstrated the impact of dietary
fibres (DF) on gut microbial communities, using not
only purified DF, such as resistant starch, β-glucan, fructo-
oligosaccharides, sugar beet peptic oligosaccharides, guar
Abbreviations: BCFA, branched-chain fatty acid; DF, dietary fibre.
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gum, pea fibre and pectin, but also DF isolated from whole
grains(11,15–18). Among the DF, purified inulin and fructo-
oligosaccharides were the first non-digestible carbohydrates
evaluated for their prebiotic properties, since they can modulate
the gut microbiota composition, with consequences on host
physiology(19).
Fruits, cereals and vegetables are the major sources of DF in
the human diet. Strong variation exists among food products
regarding the amount and the type of DF they provide(20,21).
Soluble DF is potentially most effective in modulating intestinal
microbiota. Carbohydrates embedded in a vegetable foodmatrix
are likely to present a different functionality comparedwith puri-
fied fractions(22).
Purified inulin and fructo-oligosaccharides, given as supple-
ment, on obesity have been highlighted in both preclinical(23,24)
and clinical studies(25,26). We have shown that only few
vegetables provide significant amounts of inulin and fructo-
oligosaccharides(21). It could be beneficial to encourage the con-
sumption of inulin-rich vegetables and fruits, in the context of
obesity, if their properties of interaction with the gut microbiota
are maintained in a food matrix, and if they exert health effect in
this particular context.
The present study addressed the question of the relevance of
inulin-rich food in the modulation of the functionality of the gut
microbiota, by performing an in vitro fermentation, using the
faecal material obtained from two groups of obese individuals,
before and after a dietary treatment differing by inulin intake.
Obese patients received either a diet based on inulin-rich vege-
tables coupled with inulin supplementation or an inulin-poor
diet coupled with maltodextrin supplementation as control for
3 months. The study assessed the ability of these treatments to
modify the faecal microbiota composition and fermentation
capacity in a humanised in vitro model of the gastrointestinal
tract.
Materials and methods
The study was approved by the Faculty Hospital Ethics
Committee of the Faculty of Medicine of the Catholic
University of Louvain (Woluwe, Belgium) and was registered
at clinicaltrial.gov as NCT03852069. The present study was con-
ducted according to guidelines laid down in the declaration of
Helsinki, and all procedures involving human patients were
approved. Written informed consent was obtained from all
patients.
The faeces of twelve obese patients (six females, six males)
ranging in age from 21 to 62 years and with a BMI> 30 kg/m2
were used. These patients were able to provide sufficient
amounts of fresh faeces before (initial phase) and after a 3-month
treatment, consisting of one of the two possible dietary
instructions: a diet based on fructan-rich vegetables (treated
group) and a diet based on vegetables poor in fructans (control
group). Moreover, the treated group was supplemented with a
daily dose (16 g) of inulin-type fructans (Fibrulin, Cosucra), and
the control group was given 16 g of maltodextrin (Cargill).
Fructan intake (g/d) was evaluated by submitting the patients
to a FFQ, and the calculation of fructans’ intake was based on the
analysis of fructan content in foodstuffs (vegetables, fruits and
cereals) as reported(21,27–29).
The true estimation of inulin and maltodextrin intake (com-
pliance) was evaluated upon bring-back of empty and unused
packets. To verify compliance related to the selected vegetable
consumption, a phone call with all the patients was organised
three times during the study (after 2 weeks, 1 and 2months of
treatment). A meeting with dietitians was also scheduled every
month to ensure that patients followed the dietary advice and
prepared their meal following the recipe book received at the
start of the intervention. This recipe book describes several rec-
ipes based on vegetables enriched in fructans for the treated
group and recipes with vegetables poor in fructans for the con-
trol group. The patients had to report weekly the number of
meals corresponding to the selected recipes, or using the vege-
tables included in the recipes prepared in another way.
Fructans intake (g/d) was evaluated by submitting the patients
to a FFQ created in order to include foodstuffs rich in fructans.
Indeed, we have previously published the quantitative analysis
of fructans in vegetables. The amount of fructans in cereals and
fruits has been calculated taking into account published data.
The questionnaire has been validated by the dietitians impli-
cated in the clinical follow-up. We propose to add the question-
naire (in French) as online Supplementary data. Using this
questionnaire, fructan intake was calculated on the basis of fruc-
tans content analysis in foodstuffs (vegetables, fruits and cereals)
as reported.
Faeces were used for in vitro fermentation of the indigestible
fibre residue of vegetables rich (salsify and Jerusalem artichoke)
and poor (asparagus, fennel, pumpkin and swede) in inulin, as
well as purified fibres (inulin and cellulose), to compare the
shifts in fermentation patterns resulting from the expected
diet-induced changes in microbiota.
For this purpose, a two-step in vitro model of the pig gastro-
intestinal tract was adapted to human samples. It consists of the
enzymatic hydrolysis of food material to simulate digestive proc-
esses occurring in the stomach and the small intestine, followed
by an in vitro batch fermentation of the indigested residues using
faeces as bacterial inoculum.
Enzymatic hydrolysis
Six vegetables were sampled in triplicates (n 3) and steamed for
20–30 min: Jerusalem artichoke (Helianthus tuberous), salsify
(Scorzonera hispanica), asparagus (Asparagus officinalis),
pumpkin (Cucurbita maxima Duchesne ssp.), fennel
(Foeniculum vulgare) and swede (Brassica napobrassica).
These vegetables were chosen because they display a variable
content of fructans, soluble DF and insoluble DF(21).
Steamed vegetables were hydrolysed in vitro with porcine
pepsin and pancreatin, to mimic digestion in the upper gut(30),
and undigested fibre residues were recovered using a 6 kDa
dialysis membrane placed in beakers containing distilled water
that were under continuous agitation. After 24 h, the undi-
gested fibre residues remaining in the dialysis membrane were
freeze-dried.
The composition of vegetables before and after enzymatic
hydrolysis is listed in Table 1.
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In vitro fermentation using human faecal inoculums
Faecal material of the patients was collected in a plastic container
with lid for a hermetic closure (Commode specimen collection
system 02-544-208, Fisher Scientific), placed under anaerobiosis
by inserting an Anaerocult C bag (Merck KG&A) and kept in a
cooler (4°C) during transportation to the laboratory for further
processing. Immediately upon arrival, faecal samples were condi-
tioned as follows in a glove box (In vivo2 1000, Dual Chambers,
HypoxiaWorkstation, Ruskinn Technologies) fedwith a streamof
N2 and gas mixture (8% H2, 8 % CO2, 84% N2): 25 g of faecal
material was introduced into sterile stomacher bags (384ml,
Nasco Whirl-Park) using sterile spoons (Spoons B01041, Nasco).
The bags were immediately quenched in liquid N2 to ensure
ultra-fast freezing, preventing the destruction of the micro-
organisms, and conditioned samples were kept in a freezer at
–80°C(31) until further use. Faeces samples were processed
within a maximum of 2 h following their emission.
The fermentationwas carried out according to the protocol of
Bindelle et al.(30) as modified by Tran et al.(32). For a given
individual, both faecal inocula, that is, faeces collected before
and after the dietary treatment, were processed on the same
day. The day before fermentation, 0·1 g of substrate sample (res-
idues of the hydrolysis of six steamed vegetables, and purified
inulin and cellulose) was weighed in triplicate into 50 ml sterile
glass vials. Three blanks served as a control. One litre of Menke
and Steingass’ buffer (pH 6·8) mixture devoid of Na2S(33) was
prepared and bubbled with N2. Mucus carriers were impregnated
with mucin agar. The next day, all procedures were performed in
the glove box at 37°C. The 25 g bag of faecal sample was thawed
by immersion in Menke and Steingass’ buffer, to yield a concen-
tration of 1:40 (w/v) and homogenised using a stomacher
(Awel microbiology, Mixwelþ) for 1min. Three mucus carriers
were placed in each glass vials, and 15ml of inoculum (faeces
and buffer) was poured into the vials containing the substrates.
These were air-tight closed and incubated in a water bath at 37°C
for 24 h. The pressure in the headspace of the bottles was read at
2, 5, 8, 12, 16, 20 and 24 h, using a Digital Pressure Gauge
(Tracker 200)(34) and converted into volume applying the law
of Boyle and Marriott.
After fermentation for 24 h, the supernatants were emptied
into 15 ml centrifuge conical tubes and stored at –20°C for
analyses of the SCFA. The gas production curve was modelled
according to the monophasic model of Groot et al.(35), which
allows describing fermentation kinetics using four parameters:
the total volume of gas produced at 24 h (A: ml/g DM); the time
at which half of the total gas volume is obtained (B: h); the
maximum rate of gas production (Rmax: ml/h per g DM) and
the time at which the maximum rate of production is reached
(Tmax: h).
Analysis of SCFA
Fermentation supernatants and inoculum of the twelve donors
used in the fermentation study were analysed for SCFA and
BCFA contents, by using a Waters 2690 HPLC system (Waters)
fitted with an Aminex HPX-87 H column (300 mm × 78 mm;
Bio-Rad Laboratories) combined with a Waters 486 tuneable
absorbance detector set at 210 nm.
In vitro fermentation data were corrected for the content of
the blanks, as well as the inocula. The sterile bottle containing
15 ml of fermentation supernatants was vortexed for 1 min,
and 2ml aliquot was centrifuged at 13 000 rpm for 15 min.
Aliquot (1·5 ml) of the supernatants was transferred to a vial,
and pH was adjusted to between one and three, using 0·1M HCl.
Statistical analysis
The analysis of the kinetic of fermentation and the SCFA of the
fermented ingredients with the faeces of two groups of obese
patients was made by comparing the two groups according to
the period before and after intervention by ANOVA, using the
MIXED procedure of SAS 9.4 software (SAS Inc.). Patients
(n 6) were considered as the experimental unit, and the period
was the effect that was tested.
Results
The compliance of powdered native inulin and maltodextrin
packets intake reached 98·4 and 95·5 % for treated and control
Table 1. Chemical composition of the ingredients and their hydrolysates used for fermentation (n 3) (g/100 g DM)
(Mean values with their standard errors)
Ingredients Hydrolysis
Starch OM CP IDF HMWSDF LMWSDF SDF TDF Fructans
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Asparagus Cooked 1·0 0·0 91·5 0·9 15·2 0·1 25·1 3·2 8·8 0·9 0·4 0·2 9·3 1·0 34·4 4·2 0·5 0·3
Hydrolysed 0·1 0·0 87·4 1·2 12·4 0·1 42·9 3·1 13·5 0·7 0·6 0·2 14·1 1·1 57·0 3·2 0·5 0·2
Fennel Cooked 14·1 0·7 88·9 1·5 9·5 0·9 26·9 0·0 11·2 0·7 0·2 0·0 11·4 0·6 38·3 0·7 0·3 0·1
Hydrolysed 0·1 0·0 82·8 2·3 7·8 0·6 53·7 0·3 16·2 0·3 0·5 0·2 16·7 0·1 70·4 4·9 0·3 0·1
Jerusalem artichoke Cooked 0·1 0·0 93·6 1·8 11·1 0·1 6·4 0·6 17·7 4·0 40·9 2·5 72·0 5·5 78·4 6·0 68·3 0·7
Hydrolysed 0·1 0·0 89·0 1·8 9·5 0·1 12·5 0·6 28·3 2·1 42·4 3·0 70·7 5·5 83·2 6·0 68·3 0·7
Pumpkin Cooked 49·3 1,6 92·8 1·5 7·4 0·4 17·2 3·1 6·8 0·4 1·1 0·9 8·0 0·9 23·8 3·3 1·1 0·4
Hydrolysed 30·5 0·4 86·2 1·7 6·5 0·6 37·8 1·8 11·0 0·5 0·9 0·3 11·9 0·2 49·7 2·8 1·3 0·5
Salsify Cooked 0·2 0·1 96·8 0·8 11·1 0·0 8·4 0·2 11·0 2·6 61·6 7·8 72·6 8·5 81·0 8·7 71·9 5·7
Hydrolysed 0·2 0·1 89·7 0·8 8·5 0·1 15·6 0·2 22·1 1·3 44·3 7·8 66·4 8·5 82·0 8·7 71·9 5·7
Swede Cooked 16·8 0·2 93·6 2·5 8·3 2·0 23·5 0·5 16·6 2·2 1·0 0·0 17·7 1·5 36·3 0·8 0·6 0·3
Hydrolysed 0·4 0·1 81·8 1·2 6·7 0·4 48·8 0·5 24·6 0·5 0·4 0·0 25·0 1·6 73·8 1·4 0·9 0·1
OM, organic matter; CP, crude protein; IDF, insoluble dietary fibre; HMWSDF, high molecular weight soluble dietary fibre; LMWSDF, low molecular weight soluble dietary fibre; SDF,
soluble dietary fibre; TDF, total dietary fibre.
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groups, respectively. Regarding the qualitative consumption of
vegetables enriched in fructans (for the treated group) or vege-
tables poor in fructans (for the control group), data are available
for five patients on six in each group. Based on the weekly
follow-up of cooked recipes, patients consumed at least a
mean of 5·6 and 4·4 of different recommended vegetables per
week in the treated and control groups, respectively, based on
the FFQ.
After 3 months of intervention, dietary fructan intake
increased significantly in the treated group, whereas no signifi-
cant effect occurred in the control group (before: 2·54 and
2·22 g/d v. after: 11·03 and 3·6 g/d for the treated group and con-
trol groups, respectively).
The results displayed in Table 1 demonstrate that the enzy-
matic hydrolysis allowed the collection of a significant amount
of fibrous residues. These results show that the hydrolysis has
led to a considerable decrease of the starch.
The faeces collected from patients used as inocula, displayed
different SCFA and BCFA contents and production profiles
according to the period (before v. after a 3-month treatment)
and the treatment undergone by the patient (treated group v.
control group) (Fig. 1).
Both treatments provoked an increase in SCFA contents of
faeces, with a significant difference for the treated group when
comparing before and after treatment, but no significant differ-
ence before and after for the control group (before: 5·89 and
5·27 mg/g v. after: 10·12 and 8·19 mg/g for treated and control
groups, respectively).
The molar ratios of butyrate (treated group) and acetate
(treated and control groups) showed a significant difference
between the two phases (butyrate before: 13·1 and 14·8 % v.
after: 17·1 and 14·9 %, for treated and control groups, respec-
tively; acetate before: 52·5 and 50·6 % v. after: 56·7 and 53·1 %
for treated and control groups, respectively).
An increase in microbial fermentation activity (gas produc-
tion) after treatment was also observed for the treated group,
since patients after a 3-month treatment displayed a faster and
more extended fermentation, as indicated by an increased
Rmax and by higher final gas volumes (A) for most ingredients.
The control group did not change gas production after treatment
(Table 2).
The fermentation kinetics of fibres and vegetable extracts
analysed in vitro also showed interesting results. The SCFA pro-
duction upon 24 h was higher for the treated group after dietary
intervention with significant differences compared with the
phase before, while the control group did not significantly
modify the fermentation profile of any of the two types of ingre-
dients (vegetables and purified fibres) (Table 3).
Indeed, we observe an increase of total SCFA in the treated
group after the dietary intervention when compared with the ini-
tial phase, for both vegetables (225–298 v. 465–521mg/g DM
before and after treatment, respectively) and purified carbohy-
drate (137–315 v. 218–512mg/g DM before and after treatment,
respectively). In addition, the main organic acids, namely,
acetate, propionate and butyrate, showed significant differences
before and after intervention.
An increase in butyrate was observed after the intervention in
the treated group for salsify, Jerusalem artichoke, asparagus and
fennel (5–12 % v. 7–14 % before and after the treatment, respec-
tively). Conversely, the control group showed a decrease in
SCFA, with slight tendencies to increased butyrate in the post-
phase (4–16 % v. 7–16 % before and after the treatment,
respectively).
The principal component analysis for parameters related to
fermentation kinetics and the SCFA production showed that in
the post-treatment phase, the total SCFA, A, Rmax, butyrate
and acetate were aligned on the same axis as the treated group.
Conversely, Tmax, B, propionate and BCFA were aligned with
the control group and inversely proportional to the treated
group, with a negative correlation (Fig. 2).
Finally, in addition to inulin, which displayed high fermenta-
tion, salsify and Jerusalem artichoke were the vegetables that
approximated inulin the most in terms of fast fermentation pat-
terns. Cellulose exhibited the slowest fermentation. Regarding
the total volume of gas produced, salsify came first, followed
by inulin, Jerusalem artichoke and swede. Again, cellulose
was the least fermentable.
Discussion
In recent decades, the importance of gut microbiota on health
has raised the attention of many, especially concerning the rela-
tionship between gut microbiota and obesity(36). Some studies
have shown that the fructan content of vegetables positively
impacts on the kinetic of fermentation associated with the gut
microbial alteration(37–39). DF is a major factor driving the com-
position and metabolic activity of colonic microbiota(19,40).
Data from epidemiological studies have shown that diets high
in fibre are associated with reduced risk of metabolic diseases,
such as diabetes and obesity, and SCFA are often presented as
key metabolites involved in the improvement of host
Fig. 1. SCFA contents in the faeces of two groups of donors before and after the
dietary treatment (molar ratio %) (n 6). Branched-chain fatty acids (BCFA)
include iso-butyrate, valerate and iso-valerate. , BCFA %; , butyrate %;
, propionate %; , acetate %.
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physiology(41,42). However, the studies relating the impact of inu-
lin on SCFA in obese humans have been obtained through the
analysis in the faecal samples, that lead to controversial data,
and do not always reflect SCFA production(25). The faecal micro-
biota following a 3-month treatment with fructans has a direct
impact on the fermentative capacity of the faeces since a faster
fermentation (assessed by gas production) was observed com-
bined with an increased butyrate and acetate production in
the treated group. The higher butyrate production at the post-
treatment period corroborated the results obtained by
Koecher et al.(11), who also analysed the inoculum of non-obese
people subjected to a diet rich in purified inulin-type fructans.
The post-intervention data obtained in the present trial also
showed an increase in total SCFA produced from the inoculum
of obese patients that were given the low-inulin diet.
The effect on total SCFA mirrored those obtained by other
authors, who specified that total production of SCFA is correlated
with the total volume of gas produced. Several criteria, such as
the type and amount of substrate ingested, colon integrity
and genetics of individual, can influence the production of
SCFA(43–45).
The content of fructan in the food products appeared to be the
major factor driving the production of SCFA, in the present inves-
tigation.Given these results and those obtained by some research-
ers in similar studies(45,46), it can be confirmed that vegetableswith
a high-fructan content increase the production of SCFA in a
human in vitro model, but to a lesser extent than the purified
inulin, although considerably more than the vegetables poor in
inulin. Even though insoluble DF are less fermentable(47), their
importance in the approach of obesity is not negligible.
Vegetables rich in insoluble fibres in the present study showed
greater parameters of fermentation kinetics and higher SCFA pro-
duction than those obtained for cellulose in an in vitro model.
SCFA are recognised fermentation products of great importance
for health, and which perform several functions, such as the
regulation of absorption of water and minerals, the reduction of
the pH of the colon thus inhibiting the development of pathogens
present, while promoting the growth of beneficial bacteria(48).
Thus, it should be understood that, the relationships between fer-
mentable carbohydrates and metabolic yield depend on the com-
position of the microbial community and the metabolic
characteristics of each anaerobic bacterium(49).
Table 2. Effects of the ingredient and the period (before and after dietary treatment) on fermentation kinetics modelled according to
Groot et al.(35)
(Mean values with their standard errors)
Ingredients Patients Period
A B Rmax Tmax
Mean SEM Mean SEM Mean SEM Mean SEM
Vegetables
Asparagus Treated Before 124b 27 8·7 1·5 10·5b 2·9 5·9 1·4
After 207a 11 8·2 1·4 15·7a 1·0 5·4 1·1
Control Before 155b 35 8·2 1·4 13·9a,b 3·3 5·7 1·3
After 135b 13 9·5 1·6 10·8b 1·5 6·7 1·9
Fennel Treated Before 141c 30 8·6 1·3 12·4b 3·5 5·9 1·3
After 230a 12 8·1 1·5 17·0a 0·9 5·8 1·2
Control Before 182b 52 8·1 1·7 17·2a 5·4 5·8 1·4
After 146b,c 19 9·2 1·6 12·4b 2·1 6·8 1·7
Jerusalem artichoke Treated Before 202b 44 8·2 1·6 21·9a,b 5·0 6·6 1·8
After 281a 10 7·4 2·1 21·3b 1·0 5·4 1·7
Control Before 217b 45 7·4 2·1 26·5a 7·3 5·8 2·1
After 197b 11 8·2 2·1 21·6b 4·4 6·6 2·2
Pumpkin Treated Before 158b 34 8·4 1·5 14·7b 3·5 6·2 1·6
After 242a 11 7·7 2·1 17·7a,b 0·9 5·3 1·7
Control Before 185b 53 7·7 2·1 20·4a 7·4 5·7 1·9
After 152b 32 8·0 2·0 14·9b 6·7 6·4 1·8
Salsify Treated Before 210b 55 7·9 1·4 23·2a,b 6·7 6·3 1·6
After 332a 18 7·3 1·8 25·3a,b 1·3 5·6 1·5
Control Before 222b 55 7·3 1·8 27·4a 7·9 5·7 1·9
After 198b 10 8·1 2·2 21·9b 4·7 6·5 2·2
Swede Treated Before 144c 34 8·5 1·3 12·9b 3·9 6·1 1·3
After 243a 17 8·3 1·5 18·1a 1·4 5·8 1·2
Control Before 184b 50 8·3 1·5 17·2a,b 5·0 5·9 1·4
After 159b,c 20 9·5 1·8 13·5a,b 2·8 7·1 2·0
Purified carbohydrate oligosaccharides
Cellulose Treated Before 77b 20 6·8 1·3 7·9 2·8 4·2 1·5
After 143a 14 5·9 1·3 12·0 1·0 3·6 1·2
Control Before 92b 16 5·9 1·3 10·4 2·2 3·3 1·0
After 75b 4 6·6 1·6 8·0 1·9 3·9 1·5
Inulin Treated Before 241b 62 8·5 1·5 24·1a,b 6·3 6·6 1·8
After 317a 18 7·4 1·4 26·1a,b 1·0 5·3 1·1
Control Before 238b 53 7·4 1·4 27·4a 7·0 5·8 1·5
After 213b 17 8·5 2·0 22·7b 4·4 6·9 1·9
A, total volume of gas produced (ml/g DM); B, time at which half of the total gas volume is obtained (h); Rmax, maximum rate of gas production (ml/h × g DM);
Tmax, time at which the maximum rate of production is reached (h).
a,b,c For one ingredient, values followed by unlike letters in a column indicate that means differed at a significance level of 0·05.
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Given the results of the present study and in comparison with
other investigations that analysed the SCFA and gut microbiota
profile(49), we expect that the large production in the present
study will correlate with the modification of the microbiota of
the intestinal tract of patients in the treated group. This was
observed by the very high rate of fermentation and the significant
production of butyrate. Apart from the ability to produce a sig-
nificant amount of SCFA during fermentation, another benefit of
a high-fibre diet is to stimulate the growth of the gut bacteria
essential for health.
Conclusion
Inulin-type fructans are involved in the modulation of the gut
microbiota and alter the production of both gas and SCFA, during
fermentation. An inulin-type fructan intervention in one group of
obese patients produced a higher gas volume and higher SCFA
amount in vitro, with a trend towards increasing amounts of
butyrate. In contrast, the control group presented a lower gas
volume and lower total SCFA, after the study trial compared
with the initial (pre-trial) phase. We thus confirm that in obese
individuals, the faecal microbiota exhibits a higher capacity to
Table 3. Impact of the ingredient and the period (before and after treatment) on total production of SCFA (mg/g DM) and molar ratio (%)
(Mean values with their standard errors)
Ingredients Patients Period
Total SCFA Acetate Propionate Butyrate BCFA
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Vegetables
Asparagus Treated Before 225b 62 52b 0·0 34a,b 0·0 5 0·0 9a 0·0
After 462a 97 56a 0·0 32b 0·0 7 0·1 5b 0·0
Control Before 242b 49 53a,b 0·2 37a 0·1 7 0·0 3b 0·0
After 235b 31 50b 0·1 36a 0·0 8 0·0 6a,b 0·0
Fennel Treated Before 245b 53 67a 0·1 22a 0·0 5b 0·0 6a,b 0·0
After 405a 65 68a 0·1 22a 0·0 7a,b 0·1 4b 0·0
Control Before 280a,b 43 63b 0·1 25a 0·1 8a,b 0·0 4b 0·0
After 252b 45 65a,b 0·1 17b 0·1 10a 0·0 8a 0·0
Jerusalem artichoke Treated Before 280b 92 57b 0·0 27a 0·1 10b 0·1 6a 0·0
After 479a 85 61b 0·0 23b 0·1 14a 0·1 2b 0·0
Control Before 293b 45 62b 0·0 27a 0·0 10b 0·0 1b 0·0
After 284b 37 67a 0·1 19c 0·0 12a,b 0·0 2b 0·0
Pumpkin Treated Before 254b 74 58b 0·0 28b 0·1 10b 0·0 4 0·0
After 437a 22 63a 0·0 20c 0·1 14a 0·0 3 0·0
Control Before 269b 45 51c 0·1 34a 0·1 10b 0·0 5 0·0
After 247b 57 50c 0·1 34a 0·1 11a,b 0·1 5 0·0
Salsify Treated Before 298b 85 72a 0·0 14c 0·0 12 0·1 2 0·0
After 521a 76 64b,c 0·0 20b 0·1 13 0·1 3 0·0
Control Before 322b 48 62c 0·1 26a 0·0 10 0·0 2 0·0
After 317b 36 66b 0·1 17b,c 0·0 13 0·0 4 0·0
Swede Treated Before 264b 53 60c 0·0 29a 0·1 6 0·0 5 0·0
After 449a 88 71a 0·0 20b 0·1 7 0·0 2 0·0
Control Before 291b 43 61c 0·0 29a 0·0 8 0·0 2 0·0
After 253b 46 67b 0·1 22b 0·1 8 0·0 3 0·0
Purified carbohydrate oligosaccharides
Cellulose Treated Before 137 18 43b 0·0 19c 0·0 10b 0·0 27a 0·0
After 218 20 38c 0·0 12d 0·0 22a 0·0 28a 0·0
Control Before 146 17 50a 0·1 27b 0·1 4c 0·1 19b 0·0
After 131 17 33d 0·1 44a 0·1 7b,c 0·0 16b 0·0
Inulin Treated Before 315b 84 58a,b 0·0 20b 0·1 21a 0·0 1c 0·0
After 512a 67 49c 0·0 25a 0·0 21a 0·0 5b 0·0
Control Before 306b 91 55b 0·1 27a 0·0 16b 0·0 2b,c 0·0
After 284b 79 59a 0·1 16c 0·0 16b 0·0 9a 0·0
BCFA, branched-chain fatty acids regrouping iso-butyrate, valerate and iso-valerate.
a,b,c,d For one ingredient, values followed by unlike letters in a column indicate that the organic acids before and after treatments differ at a significance level of 0·05.
Fig. 2. Principal component analysis for kinetic parameters and SCFA of
fermented ingredients after the treatment (n 6). BCFA, branched-chain fatty acids.
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modulate SCFA production when they were pretreated with a
diet rich and supplemented with inulin. The relevance of such
effects on the metabolic response towards inulin-rich diet in a
large cohort of obese patients is currently under investigation.
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